A Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Doses in Healthy Volunteers and Multiple Doses in CHB Subjects
Clinical trial NCT05001022 · TERMINATED
Trial details
- NCT number
- NCT05001022
- Sponsor
- Aligos Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-25
- Primary completion
- 2022-07-18
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.